Patents by Inventor Akihiro Masuyama

Akihiro Masuyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150307549
    Abstract: Provided is an agent having at least one of an improving effect on vascular endothelial functions and an inhibitory effect on vascular intimal thickening, as well as a prophylactic of arteriosclerosis, which have excellent safety, improve functions associated with the vascular endothelium, have effects of preventing various diseases associated with vascular endothelial functions and of inhibiting vascular intimal thickening, and may be expected to provide prophylactic effect on arteriosclerosis. The agents of the present invention contain, as an active component: (a) Xaa-Pro-Pro, (b) a hydrolysate of animal milk casein containing Xaa-Pro-Pro, or a concentrate thereof, or (c) a fermentation product containing Ile-Pro-Pro and/or Val-Pro-Pro obtained by fermenting a starting material containing milk protein with a bacterial strain of the species Lactobacillus helveticus.
    Type: Application
    Filed: July 8, 2015
    Publication date: October 29, 2015
    Applicant: CALPIS Co., LTD
    Inventors: Tatsuhiko HIROTA, Teppei NAKAMURA, Kohji OHKI, Akihiro MASUYAMA, Toshiaki TAKANO, Toshikazu YOSHIKAWA, Yuji NAITO, Hiroshi ICHIKAWA, Satomi AKAGIRI
  • Patent number: 8877483
    Abstract: An accelerating agent for elimination of dioxins which comprises, as an active ingredient, a microorganism having an activity of accelerating elimination of dioxins in the body to the outside of the body.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: November 4, 2014
    Assignee: Calpis Co., Ltd.
    Inventors: Tadashi Shinoda, Akihiro Masuyama, Hidetoshi Morita, Hiroshi Yoshikawa
  • Publication number: 20120035096
    Abstract: There is provided an agent having at least one of an improving effect on vascular endothelial functions and an inhibitory effect on vascular intimal thickening, as well as a prophylactic of arteriosclerosis, which have excellent safety, improve functions associated with the vascular endothelium, have effects of preventing various diseases associated with vascular endothelial functions and of inhibiting vascular intimal thickening, and may be expected to provide prophylactic effect on arteriosclerosis or the like. The agents of the present invention contain, as an active component: (a) Xaa-Pro-Pro, (b) a hydrolysate of animal milk casein containing Xaa-Pro-Pro, or a concentrate thereof, or (c) a fermentation product containing Ile-Pro-Pro and/or Val-Pro-Pro obtained by fermenting a starting material containing milk protein with a bacterial strain of the species Lactobacillus helveticus.
    Type: Application
    Filed: October 21, 2011
    Publication date: February 9, 2012
    Applicant: CALPIS CO., LTD.
    Inventors: Tatsuhiko HIROTA, Teppei NAKAMURA, Kohji OHKI, Akihiro MASUYAMA, Toshiaki TANAKO, Toshikazu YOSHIKAWA, Yuji NAITO, Hiroshi ICHIKAWA, Satomi AKAGIRI
  • Patent number: 8097246
    Abstract: The invention provides functional food and beverage that produce, through oral intake, a promotive effect on normal epidermal keratinization, and an epidermal differentiation and keratinization promoter for use in such functional food and beverage. The epidermal differentiation and keratinization promoter of the present invention contains, as an active component, fermented milk whey obtained by fermentation of milk with bacteria including lactic acid bacteria, such as Latobacillus helveticus. The functional food and beverage for promoting epidermal keratinization of the present invention contains the epidermal differentiation and keratinization promoter.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: January 17, 2012
    Assignee: Calpis Co., Ltd.
    Inventors: Hidehiko Baba, Akihiro Masuyama, Chiaki Yoshimura
  • Patent number: 8067034
    Abstract: Disclosed are agents for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm and for improving a circadian rhythm, as well as functional food containing such an agent, which may prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency. The agent contains whey as the active component.
    Type: Grant
    Filed: December 7, 2007
    Date of Patent: November 29, 2011
    Assignee: CALPIS Co., Ltd
    Inventors: Yoshinori Moriyama, Seiji Tsuboi, Akihiro Masuyama, Toshiaki Takano, Keita Ueno, Toshiyuki Kai
  • Patent number: 7785633
    Abstract: The present invention provides an agent for preventing or suppressing hepatic dysfunction which may be taken daily and continuously, has excellent safety, and is capable of effectively preventing and/or suppressing hepatic dysfunction, such as hepatocellular necrosis, and functional food, such as foods for specified health uses, for preventing or suppressing hepatic dysfunction containing this agent. The agent for preventing or suppressing hepatic dysfunction of the present invention contains whey as the active component, and the functional food for preventing or suppressing hepatic dysfunction contains the agent for preventing or suppressing hepatic dysfunction.
    Type: Grant
    Filed: December 7, 2007
    Date of Patent: August 31, 2010
    Assignee: Calpis Co., Ltd
    Inventors: Yoshinori Moriyama, Seiji Tsuboi, Akihiro Masuyama, Toshiaki Takano, Teppei Nakamura
  • Publication number: 20100166877
    Abstract: The invention provides functional food and beverage that produce, through oral intake, a promotive effect on normal epidermal keratinization, and an epidermal differentiation and keratinization promoter for use in such functional food and beverage. The epidermal differentiation and keratinization promoter of the present invention contains, as an active component, fermented milk whey obtained by fermentation of milk with bacteria including lactic acid bacteria, such as Latobacillus helveticus. The functional food and beverage for promoting epidermal keratinization of the present invention contains the epidermal differentiation and keratinization promoter.
    Type: Application
    Filed: June 23, 2006
    Publication date: July 1, 2010
    Applicant: Calpis Co., Ltd
    Inventors: Hidehiko Baba, Akihiro Masuyama, Chiaki Yoshimura
  • Publication number: 20100151039
    Abstract: The present invention provides functional food and beverage that produce a skin moisturizing effect through oral intake, that is excellently safe, and that may be taken regularly. The invention also provides a skin moisturizer for oral intake to be used in the functional food and beverage, as well as use thereof. The present skin moisturizer for oral intake contains as an active component fermented milk whey obtained by fermentation of milk with Lactobacillus helveticus, and the present functional food and beverage contains the skin moisturizer and has a skin moisturizing effect.
    Type: Application
    Filed: February 24, 2010
    Publication date: June 17, 2010
    Applicant: CALPIS CO., LTD.
    Inventors: Chiaki Yoshimura, Akihiro Masuyama
  • Publication number: 20090299036
    Abstract: There is provided an agent having at least one of an improving effect on vascular endothelial functions and an inhibitory effect on vascular intimal thickening, as well as a prophylactic of arteriosclerosis, which have excellent safety, improve functions associated with the vascular endothelium, have effects of preventing various diseases associated with vascular endothelial functions and of inhibiting vascular intimal thickening, and may be expected to provide prophylactic effect on arteriosclerosis or the like. The agents of the present invention contain, as an active component: (a) Xaa-Pro-Pro, (b) a hydrolysate of animal milk casein containing Xaa-Pro-Pro, or a concentrate thereof, or (c) a fermentation product containing Ile-Pro-Pro and/or Val-Pro-Pro obtained by fermenting a starting material containing milk protein with a bacterial strain of the species Lactobacillus helveticus.
    Type: Application
    Filed: February 14, 2007
    Publication date: December 3, 2009
    Applicant: Calpis Co, Ltd
    Inventors: Tatsuhiko Hirota, Teppei Nakamura, Kohji Ohki, Akihiro Masuyama, Toshiaki Takano, Toshikazu Yoshikawa, Yuji Naito, Hiroshi Ichikawa, Satomi Akagiri
  • Publication number: 20090104167
    Abstract: Disclosed is a method for producing an estrogen-like active intermediate (e.g., secoisolariciresinol) by culturing a lignan (e.g., a lignan derived from Eucommia ulmoides) together with a bacterium Lactobacillus acidophilus. Also disclosed a prophylactic/ameliorating agent for menopausal disorder and a functional beverage/food for preventing/ameliorating menopausal disorder comprising a lignan cultured together with a bacterium Lactobacillus acidophilus as an active ingredient.
    Type: Application
    Filed: July 27, 2006
    Publication date: April 23, 2009
    Applicant: Calpis Co., Ltd.
    Inventors: Masao Hattori, Norio Nakamura, Chiaki Yoshimura, Akihiro Masuyama, Toshiaki Takano
  • Publication number: 20080268065
    Abstract: The invention provides agents for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm and for improving a circadian rhythm, which may be taken daily and continuously, have excellent safety, and may effectively prevent or ameliorate disorders of an endogenous melatonin secretion rhythm or of a circadian rhythm without administration of exogenous melatonin, as well as functional food containing such an agent, which may prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency. The agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm according to the invention contains whey as the active component. The functional food for improving an endogenous melatonin secretion rhythm according to the invention contains the agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm.
    Type: Application
    Filed: December 7, 2007
    Publication date: October 30, 2008
    Inventors: Yoshinori MORIYAMA, Seiji Tsuboi, Akihiro Masuyama, Toshiaki Takano, Keita Ueno, Toshiyuki Kai
  • Publication number: 20080085321
    Abstract: The present invention provides an agent for preventing or suppressing hepatic dysfunction which may be taken daily and continuously, has excellent safety, and is capable of effectively preventing and/or suppressing hepatic dysfunction, such as hepatocellular necrosis, and functional food, such as foods for specified health uses, for preventing or suppressing hepatic dysfunction containing this agent. The agent for preventing or suppressing hepatic dysfunction of the present invention contains whey as the active component, and the functional food for preventing or suppressing hepatic dysfunction contains the agent for preventing or suppressing hepatic dysfunction.
    Type: Application
    Filed: December 7, 2007
    Publication date: April 10, 2008
    Inventors: Yoshinori MORIYAMA, Seiji Tsuboi, Akihiro Masuyama, Toshiaki Takano, Teppei Nakamura
  • Publication number: 20070224285
    Abstract: The present invention provides an agent for preventing or suppressing hepatic dysfunction which may be taken daily and continuously, has excellent safety, and is capable of effectively preventing and/or suppressing hepatic dysfunction, such as hepatocellular necrosis, and functional food, such as foods for specified health uses, for preventing or suppressing hepatic dysfunction containing this agent. The agent for preventing or suppressing hepatic dysfunction of the present invention contains whey as the active component, and the functional food for preventing or suppressing hepatic dysfunction contains the agent for preventing or suppressing hepatic dysfunction.
    Type: Application
    Filed: March 31, 2005
    Publication date: September 27, 2007
    Applicant: CALPIS CO., LTD
    Inventors: Yoshinori Moriyama, Seiji Tsuboi, Akihiro Masuyama, Toshiaki Takano, Teppei Nakamura
  • Publication number: 20070207134
    Abstract: The invention provides agents for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm and for improving a circadian rhythm, which may be taken daily and continuously, have excellent safety, and may effectively prevent or ameliorate disorders of an endogenous melatonin secretion rhythm or of a circadian rhythm without administration of exogenous melatonin, as well as functional food containing such an agent, which may prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency. The agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm according to the invention contains whey as the active component. The functional food for improving an endogenous melatonin secretion rhythm according to the invention contains the agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm.
    Type: Application
    Filed: March 31, 2005
    Publication date: September 6, 2007
    Inventors: Yoshinori Moriyama, Seiji Tsuboi, Akihiro Masuyama, Toshiaki Takano, Keita Ueno, Toshiyuki Kai
  • Publication number: 20070122454
    Abstract: The present invention provides functional food and beverage that produce a skin moisturizing effect through oral intake, that is excellently safe, and that may be taken regularly. The invention also provides a skin moisturizer for oral intake to be used in the functional food and beverage, as well as use thereof. The present skin moisturizer for oral intake contains as an active component fermented milk whey obtained by fermentation of milk with Lactobacillus helveticus, and the present functional food and beverage contains the skin moisturizer and has a skin moisturizing effect.
    Type: Application
    Filed: December 24, 2004
    Publication date: May 31, 2007
    Inventors: Chiaki Yoshimura, Akihiro Masuyama
  • Publication number: 20050201997
    Abstract: An accelerating agent for elimination of dioxins which comprises, as an active ingredient, a microorganism having an activity of accelerating elimination of dioxins in the body to the outside of the body.
    Type: Application
    Filed: May 30, 2003
    Publication date: September 15, 2005
    Applicant: CALPIS CO., LTD.
    Inventors: Tadashi Shinoda, Akihiro Masuyama, Hidetoshi Morita, Hiroshi Yoshikawa
  • Patent number: 6596301
    Abstract: An anti-stress agent and functional food containing the anti-stress agent and having an anti-stress effect, which contain as an effective ingredient fermented sour milk prepared by, for example, fermenting animal milk starting material with lactic acid bacteria of the genus Lactobacillus, which can be taken repeatedly and daily without any problems with safety, and which can mitigate and prevent mental and physical symptoms caused by stress.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: July 22, 2003
    Assignees: Danone, Groupe, Calpis Co., Ltd.
    Inventors: Akihiro Masuyama, Masaaki Yasui
  • Patent number: 6410685
    Abstract: The invention provides a method for reducing stress comprising administering an anti-stress agent winch can be administered repeatedly and daily without any problems with safety, and which can mitigate and prevent mental and physical symptoms cause by stress. The anti-stress gent comprises as an effective ingredient a tripeptide, particularly Ile-Pro-Pro and/or Val-Pro-Pro and/or a salt thereof, having angiotensin converting enzyme inhibitory activity.
    Type: Grant
    Filed: March 15, 2000
    Date of Patent: June 25, 2002
    Assignee: Calpis Co., Ltd.
    Inventors: Akihiro Masuyama, Toshiaki Takano
  • Patent number: 6284243
    Abstract: A physiologically functional food having brain function-improving, learning ability-enhancing and memory-enhancing functions, which comprises as an active ingredient a lactic acid bacterium fermented milk, a lactic acid bacterium and yeast co-fermented milk, or a treated product thereof, or a mixture thereof, optionally also including a pharmaceutically or nutritionally acceptable carrier or diluent.
    Type: Grant
    Filed: July 10, 1996
    Date of Patent: September 4, 2001
    Assignee: Calpis Co., Ltd.
    Inventors: Akihiro Masuyama, Masaaki Yasui, Hidehiko Yokogoshi, Masahiko Nomura